Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients

Autor: Kuiper, J.L., Heideman, D.A.M., Thunnissen, E., Paul, M.A., van Wijk, A.W., Postmus, P.E., Smit, E.F.

Publikováno v: In Lung Cancer July 2014 85(1):19-24

Vergoeding van schade na strafvorderlijk overheidsoptreden in het gemoderniseerde Wetboek van Strafvordering. (Dutch/Flemish)

Autor: Hirsch Ballin, M.F.H., Nieuwland, G.C., van Wijk, A.W.

Publikováno v: Tijdschrift Modernisering Strafvordering; 2022, Vol. 5 Issue 1, p11-25, 15p

Sorafenib in pretreated patients with advanced non-small lung cancer harbouring a K-ras mutation

Autor: Dingemans, A.M.C., van Wijk, A.W., Hochstenbag, M., Thunnissen, F.B.J.M., Meulemans, E.W. M, Smit, E.F.

Publikováno v: Dingemans, A M C, van Wijk, A W, Hochstenbag, M, Thunnissen, F B J M, Meulemans, E W M & Smit, E F 2009, ' Sorafenib in pretreated patients with advanced non-small lung cancer harbouring a K-ras mutation ', Journal of Thoracic Oncology, vol. 4, no. 9, pp. S414-S415 .
Journal of Thoracic Oncology, 4(9), S414-S415. International Association for the Study of Lung Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dd915aae95d9b6979c01804a65736a4a
https://research.vumc.nl/en/publications/beefadee-0054-4943-a676-823736a0ea90

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.